These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4403266)

  • 1. [The treatment of sympatheticotonic false regulations with Visken].
    Rosenkranz KA
    Munch Med Wochenschr; 1972 Jun; 114(24):1154-8. PubMed ID: 4403266
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta adrenergic receptor blockaders in the treatment of cardiac arrhythmias].
    Benchimol AB; Saad EA
    Hospital (Rio J); 1970 Jul; 78(1):1-33. PubMed ID: 4394930
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical-pharmacological studies with a new beta receptor blocking substance (LB 46, Visken)].
    Judmaier G; Dienstl F; Schwingshackl H; Amor H
    Wien Klin Wochenschr; 1970 Dec; 82(50):891-3. PubMed ID: 5491146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decrease in ventricular frequency in auricular fibrillation using Visken].
    Bender F; Dürholz HH; Gradaus D; Schmidt E
    Med Welt; 1971 Feb; 9():340-1. PubMed ID: 4396541
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of beta-receptor blocking drugs on the heart rate during submaximal exercise.
    Floor-Wieringa A; Van Strik R; Kesteloot H; Sluyts R
    Eur J Pharmacol; 1970; 10(3):303-10. PubMed ID: 4393072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
    Liljedal J
    Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials with a new beta-sympatholytic agent].
    Beyreder J; Brandstetter G
    Wien Med Wochenschr; 1973 Feb; 123(6):76-81. PubMed ID: 4405628
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of sympathicotonic cardiovascular dysregulations].
    Krüger K
    Med Klin; 1971 Aug; 66(35):1163-8. PubMed ID: 4398324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic and phonocardiographic changes after propranolol in sympathotonia].
    Aigner A; Baumgartl P; Bolzano K; Raas E
    Dtsch Med Wochenschr; 1970 Dec; 95(52):2604-7. PubMed ID: 5487514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug].
    Motolese M
    Boll Chim Farm; 1970 Jun; 109(6):363-8. PubMed ID: 4394953
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of adrenergic beta receptor blockaders on centrally caused sympathetic hyperactivity in children].
    Diekmann L; Höhfeld J
    Arztl Forsch; 1971 Oct; 25(10):335-40. PubMed ID: 4398952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dosage problems in drug therapy with beta receptor blockers and the effect of their isomers in local anesthesia].
    Machtens E
    Dtsch Zahnarztl Z; 1971 Mar; 26(3):353-8. PubMed ID: 4396335
    [No Abstract]   [Full Text] [Related]  

  • 13. Heart rate response to certain physiological manoeuvres: proposed measure of degree of -receptor blockade.
    Fitzgerald JD; Rowlands DJ; Howitt G; Davies ET
    Br Heart J; 1971 Jul; 33(4):614. PubMed ID: 4397630
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gilutensin-Heptaminol in vegetative circulatory regulation disorders].
    Aschke J; Trieb G; Nusser E
    Med Klin; 1970 Oct; 65(43):1878-83. PubMed ID: 5476058
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of an adrenergic beta receptor blockader (Kö 592) on respiration].
    Hamm J; Hunekohl E; Schmidt A
    Klin Wochenschr; 1970 Apr; 48(8):457-64. PubMed ID: 4397467
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise.
    Aellig WH; Prichard BN
    Br J Pharmacol; 1970 May; 39(1):193P-194P. PubMed ID: 4392962
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
    Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular-active agents. Problems of dosage and adverse effects].
    Baedeker W
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):315-9. PubMed ID: 4402116
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on 1-(6'-chloro-3'-methylphenoxy)-3-tert.-butylaminopropane-2-olhydrochloride (KL 255). 3. Effect of intrevenous administration on the normal and fully digitalized organism].
    Waterloh E; Rittel HF; Leide E
    Arzneimittelforschung; 1969 Oct; 19(10):1704-10. PubMed ID: 5395372
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.